Trials / Completed
CompletedNCT00783978
Surfactant Disorders and Chronic Lung Disease
Surfactant Disorders Associated With Chronic Lung Disease in Children.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 58 (actual)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Academic / Other
- Sex
- All
- Age
- 1 Month – 17 Years
- Healthy volunteers
- Not accepted
Summary
Interstitial lung diseases (ILD) in children represent a heterogeneous group of rare and not well defined disorders. Genetic abnormalities of surfactant proteins B (SFTPB) and more recently C (SFTPC) have been shown to be related to these pathologies. However, variability in the lung disease phenotype suggests the involvement of other surfactant-associated genes such as ABCA3 (ATP-binding cassette, sub-family A, member, 3). Thus, the aim of this project is: 1) to assess the prevalence of SFTPC mutation in children with chronic lung diseases, 2) to precise clinical and radiological features of children with SFTPC mutation, and 3) to identify environmental or genetic factors that may explain the extreme variability of this disease.
Detailed description
The first stage of this project will be to constitute a clinical, radiological, biological database of children (1 moth-17 years) with severe respiratory distress and/or an unexplained chronic ILD. Mutations in SFTPC, SFTPB and ABCA3 will be further identified by sequencing and documented with using the parents blood samples.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | whole blood sample | 2 ml of whole blood for children 5 ml of whole blood for parents that will be used only if 1 mutation is found in children |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2012-06-01
- Completion
- 2012-06-01
- First posted
- 2008-11-03
- Last updated
- 2012-11-19
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00783978. Inclusion in this directory is not an endorsement.